Danyu You

Danyu You

Auto-generated profile, based on publicly available information

Danyu You

Department of Nephrology, Blood Purification Research Center, The First Affiliated Hospital Fujian Medical University Fuzhou China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 October 2019 in Research Square
Verified
Preprint
Open access
DYDanyu You
Danyu You
CLCongwei Luo
Congwei Luo
LYLiyan Yang
Liyan Yang
JCJiong Cui
Jiong Cui
YCYi Chen
Yi Chen
JWJianxin Wan
Jianxin Wan
Background To identify the role of the interaction of complement fragment 3a (C3a) and its receptor C3aR in uric acid (UA) or lipopolysaccharide (LPS)-induced CCL2 expression in human renal proximal tubular epithelial cell line HK-2.Methods HK-2 cells were cultured in vitro and treated with UA or LPS to induce the production of CCL2. To determine the role of C3a-C3aR interaction in CCL2 production, HK-2 cells exposed to UA or LPS were pretreated with the small molecule sb290157 (1μmol/l) or recombinant C3a protein (100nmol/l) to block or amplify C3a-C3aR interaction. The expression of CCL2, C3 and C3aR were detected by real-time quantitative PCR (Q-PCR), enzyme-linked immunosorbent assay (ELISA) and Western Blotting.Results 12 hours of UA (150μmol/L) stimulation or 8 hours of LPS (5μg/ml) treatment significantly induced CCL2 and C3 mRNA transcription in HK-2 cells. The expression of CCL2 induced by UA or LPS could be abrogated by C3aR blockade. C3a stimulation alone has little effect on inducing CCL2 expression in HK-2 cells. However, when it stimulated the HK-2 cells together with UA or LPS, it could remarkably potentiate UA or LPS-induced CCL2 expression.Conclusion The activation of C3aR provides an important co-stimulating signal for CCL2 production in HK-2 cells and blocking the interaction of C3a-C3aR will significantly inhibit UA or LPS induced CCL2 production.

11 October 2026 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
KNKun Nie
Kun Nie
XGXiaowei Gao
Xiaowei Gao
MLMinggang Liu
Minggang Liu
DYDanyu You
Danyu You
MWMengjie Weng
Mengjie Weng
LYLiyan Yang
Liyan Yang
Minimal change disease (MCD) frequently relapses, and infection is one of the most common clinical triggers. Arachidonic acid (AA), an inflammatory lipid mediator released during tissue injury and infection, has been implicated in podocyte injury, but its contribution to metabolic dysfunction in MCD remains unclear. Here, we investigated whether AA aggravates PAN‐induced podocyte injury and examined the involvement of pyruvate kinase M2 (PKM2)‐associated metabolic dysfunction. In a puromycin aminonucleoside (PAN)‐induced rat model, AA exposure increased serum AA levels, aggravated proteinuria, reduced nephrin expression, promoted foot‐process effacement and exacerbated mitochondrial dysfunction. AA was also associated with reduced PKM1 and PKM2 abundance, increased PKM2 (Tyr105) phosphorylation, decreased pyruvate kinase activity and lower pyruvate, lactate and ATP levels. In cultured human podocytes, AA intensified PAN‐induced cytoskeletal disruption, mitochondrial dysfunction, oxidative stress and apoptosis. Pharmacological activation of PKM2 with TEPP‐46 partially restored PK‐associated metabolic activity, improved mitochondrial readouts and attenuated podocyte injury in vitro. These findings suggest that AA exacerbates PAN‐induced podocyte injury in association with PKM2‐associated metabolic dysfunction and mitochondrial stress.